Pressure Overload Is Associated With Low Levels of Troponin I and Myosin Binding Protein C Phosphorylation in the Hearts of Patients With Aortic Stenosis

Overview

Journal Front Physiol

Date 2020 Apr 9

PMID 32265736

Citations 2

Authors

Oneal Copeland

Andrew Messer

Andrew Jabbour

Corrado Poggesi

Sanjay Prasad

Steven Marston

Affiliations

Soon will be listed here.

Abstract

In previous studies of septal heart muscle from HCM patients with hypertrophic obstructive cardiomyopathy (HOCM, LVOT gradient 50-120 mmHg) we found that the level of phosphorylation of troponin I (TnI) and myosin binding protein C (MyBP-C) was extremely low yet samples from hearts with HCM or DCM mutations that did not have pressure overload were similar to donor heart controls. We therefore investigated heart muscle samples taken from patients undergoing valve replacement for aortic stenosis, since they have pressure overload that is unrelated to inherited cardiomyopathy. Thirteen muscle samples from septum and from free wall were analyzed (LVOT gradients 30-100 mmHg) The levels of TnI and MyBP-C phosphorylation were determined in muscle myofibrils by separating phosphospecies using phosphate affinity SDS-PAGE and detecting with TnI and MyBP-C specific antibodies. TnI was predominantly monophosphorylated and total phosphorylation was 0.85 ± 0.03 molsPi/mol TnI. This phosphorylation level was significantly different ( < 0.0001) from both donor heart TnI (1.6 ± 0.06 molsPi/mol TnI) and HOCM heart TnI (0.19 ± 0.04 molsPi/mol TnI). MyBP-C is phosphorylated at up to four sites. In donor heart the 4P and 3P species predominate but in the pressure overload samples the 4P species was much reduced and 3P and 1P species predominated. Total phosphorylation was 2.0 ± 0.2 molsPi/mol MyBP-C ( = 8) compared with 3.4 ± 0.07 ( = 21) in donor heart and 1.1 ± 0.1 ( = 10) in HOCM heart. We conclude that pressure overload may be associated with substantial dephosphorylation of troponin I and MyBP-C.

Citing Articles

Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics.

Tucholski T, Cai W, Gregorich Z, Bayne E, Mitchell S, Mcilwain S Proc Natl Acad Sci U S A. 2020; 117(40):24691-24700.

PMID: 32968017 PMC: 7547245. DOI: 10.1073/pnas.2006764117.

Investigating the role of uncoupling of troponin I phosphorylation from changes in myofibrillar Ca(2+)-sensitivity in the pathogenesis of cardiomyopathy.

Messer A, Marston S Front Physiol. 2014; 5:315.

PMID: 25202278 PMC: 4142463. DOI: 10.3389/fphys.2014.00315.

References

Layland J, Cave A, Warren C, Grieve D, Sparks E, Kentish J . Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I. FASEB J. 2005; 19(9):1137-9. DOI: 10.1096/fj.04-2519fje. View

Memo M, Leung M, Ward D, Dos Remedios C, Morimoto S, Zhang L . Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity. Cardiovasc Res. 2013; 99(1):65-73. DOI: 10.1093/cvr/cvt071. View

Sadayappan S, Gulick J, Klevitsky R, Lorenz J, Sargent M, Molkentin J . Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background. Circulation. 2009; 119(9):1253-62. PMC: 2656413. DOI: 10.1161/CIRCULATIONAHA.108.798983. View

Bates E . Treatment options in severe aortic stenosis. Circulation. 2011; 124(3):355-9. DOI: 10.1161/CIRCULATIONAHA.110.974204. View

Messer A, Gallon C, McKenna W, Dos Remedios C, Marston S . The use of phosphate-affinity SDS-PAGE to measure the cardiac troponin I phosphorylation site distribution in human heart muscle. Proteomics Clin Appl. 2010; 3(12):1371-82. DOI: 10.1002/prca.200900071. View

Bayliss C, Jacques A, Leung M, Ward D, Redwood C, Gallon C . Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T. Cardiovasc Res. 2012; 97(3):500-8. DOI: 10.1093/cvr/cvs322. View

Champion H . Targeting protein phosphatase 1 in heart failure. Circ Res. 2005; 96(7):708-10. DOI: 10.1161/01.RES.0000164359.95588.25. View

Copeland O, Sadayappan S, Messer A, Steinen G, van der Velden J, Marston S . Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle. J Mol Cell Cardiol. 2010; 49(6):1003-11. DOI: 10.1016/j.yjmcc.2010.09.007. View

El-Armouche A, Pamminger T, Ditz D, Zolk O, Eschenhagen T . Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts. Cardiovasc Res. 2004; 61(1):87-93. DOI: 10.1016/j.cardiores.2003.11.005. View

10.

Messer A, Jacques A, Marston S . Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J Mol Cell Cardiol. 2006; 42(1):247-59. DOI: 10.1016/j.yjmcc.2006.08.017. View

11.

Song W, Dyer E, Stuckey D, Copeland O, Leung M, Bayliss C . Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse. J Biol Chem. 2011; 286(31):27582-93. PMC: 3149350. DOI: 10.1074/jbc.M111.252320. View

12.

Li A, Estigoy C, Raftery M, Cameron D, Odeberg J, Ponten F . Heart research advances using database search engines, Human Protein Atlas and the Sydney Heart Bank. Heart Lung Circ. 2013; 22(10):819-26. DOI: 10.1016/j.hlc.2013.06.006. View

13.

Elliott P, McKenna W . Hypertrophic cardiomyopathy. Lancet. 2004; 363(9424):1881-91. DOI: 10.1016/S0140-6736(04)16358-7. View

14.

Piroddi N, Witjas-Paalberends E, Ferrara C, Ferrantini C, Vitale G, Scellini B . The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM. J Gen Physiol. 2018; 151(1):18-29. PMC: 6314385. DOI: 10.1085/jgp.201812160. View

15.

Zaremba R, Merkus D, Hamdani N, Lamers J, Paulus W, Dos Remedios C . Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies. Proteomics Clin Appl. 2010; 1(10):1285-90. DOI: 10.1002/prca.200600891. View

16.

Jacques A, Briceno N, Messer A, Gallon C, Jalilzadeh S, Garcia E . The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy. Cardiovasc Res. 2008; 79(3):481-91. PMC: 2492731. DOI: 10.1093/cvr/cvn094. View

17.

Messer A, Bayliss C, El-Mezgueldi M, Redwood C, Ward D, Leung M . Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation. Arch Biochem Biophys. 2016; 601:113-20. PMC: 4909753. DOI: 10.1016/j.abb.2016.03.027. View

18.

Barefield D, Sadayappan S . Phosphorylation and function of cardiac myosin binding protein-C in health and disease. J Mol Cell Cardiol. 2009; 48(5):866-75. PMC: 6800196. DOI: 10.1016/j.yjmcc.2009.11.014. View

19.

Layland J, Solaro R, Shah A . Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovasc Res. 2005; 66(1):12-21. DOI: 10.1016/j.cardiores.2004.12.022. View

20.

Kinoshita E, Kinoshita-Kikuta E, Takiyama K, Koike T . Phosphate-binding tag, a new tool to visualize phosphorylated proteins. Mol Cell Proteomics. 2005; 5(4):749-57. DOI: 10.1074/mcp.T500024-MCP200. View